320.10
전일 마감가:
$335.80
열려 있는:
$330
하루 거래량:
335.01K
Relative Volume:
0.97
시가총액:
$35.10B
수익:
$4.56B
순이익/손실:
$-176.77M
주가수익비율:
-186.35
EPS:
-1.7177
순현금흐름:
$225.30M
1주 성능:
-6.91%
1개월 성능:
+1.97%
6개월 성능:
+53.67%
1년 성능:
+0.00%
Beone Medicines Ltd Adr Stock (ONC) Company Profile
명칭
Beone Medicines Ltd Adr
전화
41-616851900
주소
C/O BEONE MEDICINES I GMBH, BASEL
ONC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-09-18 | 개시 | Barclays | Overweight |
2025-04-07 | 개시 | RBC Capital Mkts | Outperform |
2025-03-03 | 업그레이드 | BofA Securities | Neutral → Buy |
2024-12-03 | 재개 | Morgan Stanley | Overweight |
2024-09-18 | 개시 | JMP Securities | Mkt Outperform |
2024-02-06 | 재개 | JP Morgan | Overweight |
2023-09-12 | 개시 | Macquarie | Outperform |
2023-08-17 | 개시 | Jefferies | Buy |
2023-07-17 | 개시 | Citigroup | Buy |
2023-06-30 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
2023-01-12 | 개시 | Daiwa Securities | Buy |
2022-10-13 | 업그레이드 | Guggenheim | Neutral → Buy |
2022-10-13 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2022-08-09 | 재개 | JP Morgan | Overweight |
2022-03-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2022-02-07 | 개시 | Deutsche Bank | Buy |
2021-10-12 | 개시 | Bernstein | Outperform |
2021-10-06 | 업그레이드 | CLSA | Underperform → Buy |
2021-03-08 | 개시 | China Renaissance | Buy |
2021-03-01 | 다운그레이드 | CLSA | Outperform → Underperform |
2020-11-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2020-11-06 | 다운그레이드 | Maxim Group | Buy → Hold |
2020-11-06 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
모두보기
Beone Medicines Ltd Adr 주식(ONC)의 최신 뉴스
Mirae Asset Global Investments Co. Ltd. Buys Shares of 3,824 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
160 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Acquired by Farther Finance Advisors LLC - Defense World
Slow Capital Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Signaturefd LLC Purchases New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
PFG Investments LLC Acquires Shares of 985 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
14,420 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - Defense World
14,420 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - MarketBeat
Perigon Wealth Management LLC Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
LVW Advisors LLC Purchases Shares of 1,022 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives $336.30 Consensus PT from Brokerages - MarketBeat
Aaron Wealth Advisors LLC Invests $200,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Brokerages Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Target Price at $336.30 - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat
John Oyler Sells 27,803 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
Avanza Fonder AB Makes New $199,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Upgraded at Zacks Research - Defense World
BeOne Medicines (NASDAQ:ONC) Coverage Initiated by Analysts at Barclays - Defense World
BeOne Medicines (NASDAQ:ONC) SVP Sells 10,006 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap UpHere's What Happened - MarketBeat
BeOne Medicines (NASDAQ:ONC) Insider Sells $1,750,300.00 in Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - MarketBeat
Beone Medicines Ltd Adr (ONC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Beone Medicines Ltd Adr 주식 (ONC) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
OYLER JOHN | Chief Executive Officer |
Sep 16 '25 |
Sale |
325.71 |
27,803 |
9,055,694 |
0 |
자본화:
|
볼륨(24시간):